CORXEL Pharmaceuticals
制药业
Our mission is to develop innovative cardiometabolic therapies globally.
关于我们
CORXEL, formerly named Ji Xing Pharmaceuticals, is a leading biotech company headquartered in US and China committed to bringing innovative science and medicines to underserved patients with serious and life-threatening cardiometabolic diseases. Backed by RTW Investments, CORXEL was founded in 2019 to develop and commercialize novel, innovative therapeutics to treat unmet medical needs in cardiometabolic diseases. With a strong and further developing asset pipeline, industry leading talent, and patient-centric focus, CORXEL is dedicated to deliver a meaningful and lasting impact on patients.
- 网站
-
http://www.jixing.com
CORXEL Pharmaceuticals的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Shanghai
- 类型
- 私人持股
- 创立
- 2019
- 领域
- Biotech和Cardiometabolic